Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
Marsh & McLennan Companies director Jane H. Lute reported new equity-based compensation in the form of restricted stock units. On February 15, 2026, she acquired 156.69 restricted stock units at $173.51 per unit as a grant or award, bringing her direct holdings to 7,351.38 units.
On February 13, 2026, an additional 37.24 units at $172.98 were credited as an "other" transaction, tied to dividend equivalents and director fees under the company’s Directors Stock Compensation Plan. Each restricted stock unit converts into one share of Marsh & McLennan Companies common stock.
Marsh & McLennan Companies director Jan Siegmund reported a small change in his equity holdings. On February 13, 2026, he received 4.88 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan as dividend equivalents credited to his account.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Siegmund directly holds a total of 943.13 restricted stock units under this plan.
Marsh & McLennan Companies director Steven A. Mills received a stock grant of common shares as part of his board compensation. On February 15, 2026, he acquired 244 shares of common stock at a reference value of $173.51 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this award, he directly owned 4,144.75 common shares. A separate line also reports 47,553 common shares held indirectly by a trust.
Marsh & McLennan Companies (Marsh) is a global professional services firm in risk, insurance, and consulting, operating in 130 countries with annual revenue of $27 billion and more than 95,000 colleagues.
The Risk and Insurance Services segment, including Marsh Risk and Guy Carpenter, generated about 64% of 2025 revenue by providing insurance broking, reinsurance and risk advisory services. The Consulting segment, led by Mercer and Marsh Management Consulting, contributed about 36% of revenue, with Mercer alone accounting for roughly 23% and managing about $692 billion in assets as of December 31, 2025.
The report highlights extensive regulatory oversight across many jurisdictions, growing exposure to cybersecurity and data privacy obligations, and emerging AI regulations. It also emphasizes competition for talent, the importance of technology and AI investments, and broad macroeconomic and geopolitical risks that could reduce client demand or disrupt operations.
Marsh & McLennan Companies, Inc. filed a current report to note that it issued a press release with its fourth quarter and full-year 2025 financial results. The company also announced a conference call to discuss these results at 8:30 a.m. Eastern time on January 29, 2026.
The press release is attached as Exhibit 99.1 and is incorporated by reference, but it is treated as furnished, not filed, for purposes of Section 18 of the Securities Exchange Act of 1934. No specific financial figures are included in this report itself.